Results 111 to 120 of about 2,541 (157)

Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. [PDF]

Pharmaceutics
Tauser RG, Lupascu FG, Profire BS, Iacob AT, Vasincu IM, Apotrosoaei M, Chirliu OM, Lupascu D, Profire L.   +8 more
europepmc   +1 more source

Neutrophil-Inspired Film for Nonadhesive Capture of Tumor Cells through Synergistic Functionalization of Zwitterions and Aptamers. [PDF]

Chem Bio Eng
Li Y, Shu R, Lu D, Zeng C, Qi F, Chen S, Zhang L, Tang Z.   +7 more
europepmc   +1 more source

DNA Tweezers with Replaceable Clamps for the Targeted Degradation of Cell Membrane Proteins. [PDF]

Pharmaceutics
Sun Y, Huang Y, Chen D, Hu S, Pan T, Liu Y, Wang R, Tan W.   +7 more
europepmc   +1 more source

Albumin-conjugation enables improved tumor targeting of aptamers via SPECT imaging. [PDF]

Mol Ther Nucleic Acids
Yang S, Zheng C, Cheng S, Wen L, Li P, Li J, Lan X, Jiang D.   +7 more
europepmc   +1 more source

Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation. [PDF]

Adv Drug Deliv Rev
Coppola G, Cennamo F, Ciccone G, Ibba ML, Ruscio AD, Vito AD, Esposito CL, Catuogno S.   +7 more
europepmc   +1 more source

Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma. [PDF]

Theranostics
Fu X, Huang J, Chen X, Xie D, Chen H, Liang Z, Wang Z, Liang Y, Lu A, Liang C.   +9 more
europepmc   +1 more source

Innovative Applications of Nucleic Acid Aptamers in Colorectal Cancer Diagnosis and Therapy: From Selection Optimization to Clinical Translation. [PDF]

Int J Nanomedicine
Lu JF, Zhang XR, Liu Y, Zhang CL, Wang L, Liu ZQ, Cai J, Yi HW.   +7 more
europepmc   +1 more source

Simultaneous targeted delivery of doxorubicin and KRAS suppression by a hybrid molecule containing miR-143 and AS1411 aptamer. [PDF]

Sci Rep
Laowichuwakonnukul K, Soontornworajit B, Arunpanichlert J, Rotkrua P.   +3 more
europepmc   +1 more source

The emerging role of aptamers in targeted cancer immunotherapy. [PDF]

Mol Ther Oncol
Zhu S, Xu R, Xu H, Wang Y, Wang L, He N, Wang HH, Ren X.   +7 more
europepmc   +1 more source

Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications. [PDF]

Small
Qin Y, Chen X, Willner I.
europepmc   +1 more source